Invenia ABUS 2.0: The Only FDA-Approved Ultrasound Technology for Breast Cancer Detection in Women with Dense Breast Tissue

The Dense Breast Dilemma

Over 40 percent of women have dense breast tissue, one of the strongest common risk factors for developing breast cancer. In dense breasts, cancers may be masked on 2D mammography – potentially delaying diagnosis in these women. Both dense breast tissue and cancer appear white on a mammogram, creating a dangerous camouflage effect and a dilemma for radiologists whose goal is to find breast cancer as early as possible.

Detecting More Cancer

GE Healthcare offers the only FDA-approved ultrasound supplemental screening technology that is specifically designed for detecting cancer in dense breast tissue. Compared to mammography alone, Invenia ABUS 2.0 imaging looks differently at dense breast tissue, providing a comprehensive view of the breast. This technology has demonstrated a 35.7% increase in cancer detection over mammography alone for these women.

Supplemental imaging with Invenia ABUS 2.0 transforms breast care from reactive to proactive. Clinical research studies demonstrate that when used as an adjunct to mammography, small cancers visible only through ABUS were predominantly invasive and node-negative. Detecting them at this earlier stage has important prognostic implications and can reduce the cost of care.

Learn More about Abus 2.0

Contact Tower Saint John’s Imaging to learn more about Automated Breast Ultrasound technology and how it can help save lives.

Tower Saint John’s Imaging Toy Drive Was a Success!

Tower Saint John’s Imaging conducted their successful Toy Drive benefiting the following organizations:

  • Salvation Army with it’s collaboration with Toys for Tots, an official mission of the Marine Corps Reserve.
  • Jewish Family Services of Los Angeles, a multi-service Agency who’s goals are to strengthen and preserve individual, family and community life.
  • Chai Lifeline, they bring joy to the lives of seriously ill children and their families.

The Power of Combining ABUS and Tomosynthesis to Find Small Cancers

40% of women have dense breast tissue and for these women, mammography screenings alone may not be enough to find breast cancer. Both cancer and dense tissue appear white on a mammogram, enabling cancer to hide.

Speaking on the benefits of utilizing Automated Breast Ultrasound to help detect cancer in dense breasts, Tower Imaging Medical Group’s Dr. Daniel Kirsch was quoted as saying, “We implement ABUS because it offers a true advance in screening ultrasound evaluation of the breast.”

Dr. Kirsch further elaborated by stating, “Studies have shown that tomosynthesis can improve cancer detection, and decrease recall rates or false positives. With the ability to see through overlapping tissue, tomosynthesis also provides improved localization and characterization of masses,” said Arnold Honick, MD, Radiologist, RCI, PLC, Radiology Consultants of Iowa in Cedar Rapids, Iowa. “However, tomosynthesis is still X-ray based and sensitivity is reduced in women with extremely dense breasts, which means that some masses will still be masked and likely not detected. This is where ABUS, utilizing a different imaging technology, is complementary to mammography and can improve overall screen-detected breast cancer.”

To view more information about Automated Breast Ultrasound, and read more about Dr. Kirsch’s statement of benefits, view the full article on Aunt Minnie’s site here:

Contact Tower Saint John’s Imaging at 310.264.9000 to schedule an ABUS exam.

Go Big or Go Bust? How Less-than-Large Radiology Practices Can Survive the Consolidation Era

Speaking on the ever-challenging environment in the radiology services industry, Tower Imaging Group’s Dr. Bruce Yawitz was featured and quoted in discussing how radiology facilities can adapt and survive the present day’s many business challenges.

Speaking on Tower Imaging’s strategical objectives, he was quoted as saying, “We pride ourselves on being a specialty-based, small boutique group, but these days I don’t think that’s enough,” says Bruce Yawitz, MD, president of Tower Imaging. “We need to have a bigger footprint, and sharing assets with other like-minded groups under the umbrella of Strategic Radiology will provide everything that’s important to our hospital partners, while allowing us to maintain the independence we’ve always cherished.”

To view the complete article, please go to the following link: Go Big or Go Bust? How Less-than-Large Radiology Practices Can Survive the Consolidation Era

Improved Diagnostic Confidence Now Available at Tower Saint John’s Imaging with the Discovery MI DR PET/CT

This innovative PET/CT imaging system from GE Healthcare may help you increase your diagnostic confidence and enhance the care of your patients. The Discovery MI DR PET/CT uses advanced detector technology and compared to previous scanners, can deliver:

  • High PET sensitivity and count rate performance to image all tracers *2 mm resolution over the entire FOV with SharpIR
  • Up to 82 percent reduction in CT dose with ASiR, at the same image quality
  • Up to 2X improvement in quantitative accuracy (SUVmean) and image quality (SNR) with Q.Clear
  • Platform compatible with advanced digital solutions designed to connect machines, people and data through a portfolio of healthcare analytics applications.

The Discovery™ MI DR PET/CT imaging system from GE Healthcare uses revolutionary LightBurst detector technology to improve scanning speed and diagnostic accuracy.

In addition to faster scanning times, this scanner will allow lower radiation dosing with new state-of-the-art LYSO detectors. Discovery MI DR was created to help clinicians diagnose and stage disease earlier and better guide treatment strategies while enabling more compelling research with more novel, faster decaying tracers. This system also features the latest diagnostic CT innovations to provide a “one-stop-shop” diagnostic experience.

With the Discovery MI DR system, we continue to raise the level of excellence in healthcare in our area. We are proud to be on the leading edge of advancing the quality of cancer and cardiac care for our local, regional and international patients.

See how this remarkably advanced PET/CT system can help make a difference in patient care by calling us at 310.264.9000 and requesting more info!

October is Breast Cancer Awareness Month

October is Breast Cancer Awareness Month, so do something important for those you love by doing something for your health. Schedule your exam today.

Breast Cancer is the second most common type of cancer for women in the United States. Whether or not you have been yet, you will be exposed to breast cancer at some point in your life. At least 1 in every 8 women will be diagnosed with it during their life. Breast screenings can save your life by detecting cancer at its earliest and most treatable stage.

Here at Tower Saint John’s Imaging, we offer the most advanced
Breast Imaging Services which include:

  • 3D Mammography (Digital Breast Tomosynthesis)
  • Automated Breast Ultrasound (ABUS)
  • Breast MRI
  • MRI-guided biopsy

Schedule your exam today by calling:
(310)264-9000 or (310)264-4009

TSJI Now Offers XOFIGO® (radium Ra 223 dichloride) INJECTIONS

Did you know that prostate cancer spreads to the bone in 9 out of 10 men with metastatic castration-resistant prostate cancer (mCRPC)? One of the reasons it may have spread is because the cancer is no longer responding to hormonal or surgical treatment that lowers testosterone.

Among the treatment options being utilized, there is a treatment called Xofigo® (radium Ra 223 dichloride) injection. Xofigo is used to treat prostate cancer that no longer responds to hormonal or surgical treatment that lowers testosterone. It is for men whose prostate cancer has spread to the bone with symptoms but not to other parts of the body.

Xofigo contains the radioactive material radium 223, which works by going to areas in the bones that are growing quickly, just like calcium does. Bone metastases are one of those rapidly growing areas. Once at the metastases, Xofigo gives off a strong energy that travels a short distance. The energy is deadly to the cancer cells in the bones but does limited damage to nearby healthy cells. Xofigo can be absorbed by other organs, primarily the bone marrow and digestive system, which may result in side effects in those healthy tissues.

Contact us at 310.264.9000 to speak to one of our radiologists about mCRPC, risk factors, symptoms and treatments like Xofigo that may be appropriate for certain patients.

You can also get more information regarding Xofigo on their website:

Tower Saint John’s Imaging is Now Contracted with Oscar Health Insurance

Tower Saint John’s Imaging is excited to announce that they are now contracted with Oscar Health Insurance!

About Oscar Health Insurance
Based out of New York City, Oscar currently offers individual health plans in parts of New York, Texas, and California. Its aim is to change Americans’ experience of engaging with the healthcare system by redesigning insurance to be geared toward the user experience.Oscar offers all members free 24/7 telemedicine visits through their Doctor on Call service as a part of their membership, which are available both through the Oscar Android or iOS app or the Oscar web app. Oscar assigns each of its members to a “Concierge Team” which is made up of a team of three care guides and a registered nurse that handle both traditional customer service questions as well as coordination of clinical care.

In an interview with the Phoenix Business Journal in 2017, Oscar’s VP of Customer Care Paul Gazely said that Oscar’s concierge model “helps to build a relationship and build trust with our members with their health care needs,” and that the model helps Oscar familiarize itself “with the member’s needs by looking at the entire member’s health history.”

In addition, Oscar offers its members Amazon gift cards as a part of a rewards program for step tracking. Oscar offers direct appointment scheduling with a selection of its provider partners, and (as of 2017) offers in-network providers an application and tools to serve Oscar members, including a Clinical Dashboard that pulls Oscar members’ medical histories into a single platform.

Tower Saint John’s Imaging is Part of the Anthem Blue Cross Network

During December of 2017 letters from Anthem Blue Cross were erroneously sent letters to patients notifying them that Tower Saint John’s Imaging is no longer part of their network. TSJI is still contracted with Anthem Blue Cross and is a part of their network, and is doing their best to notify all of their patients of this error.TSJI and Anthem Blue Cross apologize for any confusion and inconvenience this mistake has caused our patients.

If you have any additional questions please reach out to Anthem Blue Cross at:
Monday-Friday, 8 a.m. to 8 p.m. ET

Join Tower Saint John’s Imaging Radiologists in a Walk to End Alzheimer’s

Tower Saint John’s Imaging Radiologists will proudly be participating in this month’s “Walk to End Alzheimer’s”. The event will be taking place in Santa Monica and is the world’s largest event to raise awareness and funds for Alzheimer’s care, support and research. This inspiring event calls on participants of all ages and abilities to join the fight against the disease!

Event Details

Our Walk
2017 Walk to End Alzheimer’s – Westside Walk


Registration at 9:00am
Ceremony at 10:00am
Walk at 10:30am

Route Length: 2 miles

Tongva Park
1615 Ocean Ave
Santa Monica, CA 90401

To join TSJI or donate to this great cause, visit our team page here: Walk to End Alzheimer’s 


Tower Saint John's Imaging is an ACR accredited facility. Call 310.264.9000 or Click to schedule appointment.SCHEDULE APPOINTMENT